Alzheimer Disease & Associated Disorders

Papers
(The median citation count of Alzheimer Disease & Associated Disorders is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Rescreening on RBANS Delayed Memory Index? Forget About It!14
A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers14
Meta-Analysis of Animal Fluency Performance in Amnestic Mild Cognitive Impairment and Cognitively Unimpaired Older Adults14
Alzheimer’s Disease Neuropathologic Change and Vitamin Supplement Use Decades Earlier14
Frequent Occurrence of Alzheimer Disease in Patients With IgE-mediated Allergies13
Asian Cohort for Alzheimer Disease (ACAD) Pilot Study13
Psychometric Evaluation of the Perceived Research Burden Assessment (PeRBA) in Longitudinal Studies of Alzheimer Disease Using Rasch Analysis13
Focusing on Earlier Management of Alzheimer Disease13
Anticipated Psychological or Behavioral Reactions to Learning Alzheimer Biomarker Results12
Effects of Depression on Changes in Cognitive Function in Older Adults11
Alzheimer Disease: A New Beginning in Therapeutics11
Characterization of Balance Control and Postural Stability in Patients With Alzheimer Disease10
Interaction of Alzheimer Disease and Traumatic Brain Injury on Cortical Thickness10
The Technology in Caring Questionnaire10
Triadic Communication in Medical Encounters Including Individuals With Dementia9
Mild Cognitive Impairment Subtype Performance in Comparison to Healthy Older Controls on the NIH Toolbox and Cogstate9
The Impact of Episodes of Lucidity on People Living With Dementia and Their Caregivers9
Risk of Neuropsychiatric Symptoms Among People Who Develop Cognitive Impairment With and Without a History of Post-traumatic Stress Disorder8
Carotid Intima-Media Thickness (cIMT) and Cognitive Performance: A Population-Based Cross-Sectional Study from North India: Erratum8
The Influence of Traffic Lights Presentation of Dementia Risk Screening Information on Older Adults’ Motivations for Risk Reduction in Primary Care Settings8
Clinical Characterization of Veterans With Alzheimer Disease by Disease Severity in the United States8
DXA-Measured Abdominal Adipose Depots and Structural Brain Integrity in Postmenopausal Women7
Exploring Social Cognition Tests to Differentiate Frontotemporal Dementia from Depression7
Application of Suggestive Biomarkers in Dementia With Lewy Bodies With Masking of Typical Clinical Symptoms by Alzheimer Disease-type Pathology7
Recruitment of a Diverse Community-based Older Adult Cohort for a Longitudinal Aging Study7
Perspectives From Black and White Participants and Care Partners on Return of Amyloid and Tau PET Imaging and Other Research Results7
Compassion Versus Accuracy6
“I′m not a risk taker”6
Hypothesis6
Mapping the Landscape of Those Left Behind When a Person With Dementia Dies6
Phase 1 Single Ascending and Multiple Ascending Dose Studies of Phosphodiesterase-9 Inhibitor E20276
MoCA Intraindividual Cognitive Variability in Older Adults With Type 1 Diabetes6
Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer6
Regional White Matter Hyperintensities Relate to Specific Cognitive Abilities in Older Adults Without Dementia5
CSF α-Synuclein and Tau as Biomarkers for Dementia With Lewy Bodies5
An Indian Young-onset Dementia With Parkinsonism With Double Heterozygous Mutations in ABCA7 and PRKN Identified Through Whole-exome Sequencing5
Psychosocial and Behavioral Outcomes for Persons With Cognitive Impairment and Caregivers Following Amyloid-β PET Scan Disclosure5
A New Presenilin-1 Missense Variant Associated With a Progressive Supranuclear Palsy-like Phenotype5
Measurement of Allostatic Load in Caregivers of Older Hispanic People With Alzheimer Disease and Related Disorders5
Meta-Analysis of White Matter Hyperintensity Volume Differences Between APOE ε4 Carriers and Noncarriers5
Feasibility and Acceptability of a Multifaceted Observational Protocol to Investigate Lucidity in Advanced Dementia5
Predictors of Cognitive Change in Parkinson Disease5
Comparison of Enlarged Perivascular Spaces in Early-Onset and Late-Onset Alzheimer Disease-related Cognitive Impairment5
Evidence of Pericyte Damage in a Cognitively Normal Cohort5
A Delphi Approach to Define Lucid Episodes in People Living With Dementia5
A Pilot Randomized Trial of a Purposeful and Stimulating Volunteer Opportunity5
One Minute of EEG Data Provides Sufficient and Reliable Data for Identifying Lewy Body Dementia5
Cognitive Impairment and the Associated Factors Among Older People in Rural Central Tanzania4
Early-onset Alzheimer Disease Associated With Neuromyelitis Optica Spectrum Disorder4
CSF1R-related Adult-onset Leukoencephalopathy4
Changes in Polypharmacy and Psychotropic Medication Use After Diagnosis of Major Neurocognitive Disorders4
Spatial and Temporal Relationships Between Atrophy and Hypometabolism in Behavioral-Variant Frontotemporal Dementia4
Predictors of Driving Cessation in Older Adults4
Association of Being Accompanied at Medical Consultation and Having Memory Complaints With Cognitive Impairment in Elderly Brazilian Outpatients4
High-Frequency rTMS Could Improve Impaired Memory in Mild Cognitive Impairment Patients in China4
Education as a Moderator of Help Seeking Behavior in Subjective Cognitive Decline4
Nasu-Hakola Disease With Stroke-like Attack4
Delirium Severity and Physical Function in Hospitalized Persons Living With Dementia4
Gray Matter Volume as Evidence for Cognitive Reserve in Bilinguals With Mild Cognitive Impairment3
Association of Moderate and Vigorous Physical Activity With Cognitive Performance3
Large Discrepancies in Dementia Mortality Reported in Vital Statistics3
Increasing the Cognitive Screening Efficiency of Global Phase III Trials in Early Alzheimer Disease3
Can Depressive Symptomatology at Diagnosis Predict Cognitive and Functional Decline Over 1 Year in Rural Canadian Patients With Dementia?3
Proteomic Analysis Reveals Potential Exosomal Biomarkers in Patients With Sporadic Alzheimer Disease3
A National Assessment of Alzheimer Disease and Antipsychotic Medication Prescribing Among Older Adults in Ambulatory Care Settings3
Aspects of Rest–Activity Rhythms Associated With Behavioral and Psychological Symptoms in Moderate and Severe Dementia3
Gut Microbiome Changes in Patients With Idiopathic Normal Pressure Hydrocephalus3
Research Priorities of Individuals and Caregivers With Lewy Body Dementia3
Family Caregiver Comorbidities in Lewy Body Dementia Versus Alzheimer Disease and Associated Disorders3
Identifying Stigmatizing Language Used by Israelis and Germans With a Mild Neurocognitive Disorder, Their Relatives, and Caregivers of People With Alzheimer’s Disease3
Dementia and Its Profound Impact on Family Members and Partners3
Musical Bridges to Memory3
Exploring Musculoskeletal Injuries Among Informal and Formal Carers of People With Dementia3
0.08683705329895